EP2303276
FUMARATE SALT OF 4-(3-CHLORO-2-FLUOROANILINO)-7-METHOXY-6-{[1-(N-METHYLCARBAMOYLMETHYL)PIPERIDIN-4-YL]OXY}QUINAZOLINE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
11.5.2009EP published:
13.11.2013EP application number:
09746098.4
EPO information:
European Patent Register
Max expiry date:
10.5.2029
Title:
FUMARATE SALT OF 4-(3-CHLORO-2-FLUOROANILINO)-7-METHOXY-6-{[1-(N-METHYLCARBAMOYLMETHYL)PIPERIDIN-4-YL]OXY}QUINAZOLINE
Timeline
Today
11.5.2009EP application
13.11.2013EP Publication
Owner
Name:
AstraZeneca ABAddress:
151 85 Södertälje, SE
Inventor
Name:
BOARDMAN, Kay, AlisonAddress:
MacclesfieldCheshire SK10 2NA, GB
Name:
HARD, Susan, ElizabethAddress:
MacclesfieldCheshire SK10 2NA, GB
Name:
DOBSON, Andrew, HornbyAddress:
MacclesfieldCheshire SK10 2NA, GB
Name:
WHITLOCK, BrianAddress:
MacclesfieldCheshire SK10 2NA, GB
Priority
Number:
52706 PDate:
13.5.2008Country:
US
Number:
110637 PDate:
3.11.2008Country:
US
Classification
Categories:
A61K 31/517, A61P 35/00